Perphenazine
40 NDCs across 11 manufacturers|40 Generic,0 Brand
Perphenazine is used to treat huntington disease, nausea, psychotic disorders, reye syndrome, schizophrenia and substance withdrawal syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Sep 10, 1987. FDA's Orange Book lists 36 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $11 million on Perphenazine across 194,000 claims for 23,000 beneficiaries.
Perphenazine is available as 40 NDCs from 11 manufacturers (40 generic, 0 brand), with NADAC prices from $0.14 to $0.39 per EA — the most expensive product costs about 2.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
40
40G / 0B
Manufacturers
11
competing in market
Price Spread
$0.14 – $0.39
per EA
7d Activity
avg -8.3% WoW · of 40 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Endo USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Phenothiazine class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing PERPHENAZINE
Frequently Asked Questions
What is Perphenazine used to treat?
Perphenazine is used to treat huntington disease, nausea, psychotic disorders, reye syndrome, schizophrenia and substance withdrawal syndrome, per the National Library of Medicine's MED-RT classification.
When did Perphenazine become available as a generic?
FDA approved the first generic Perphenazine (ANDA) on Sep 10, 1987. The Orange Book currently lists 36 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Perphenazine?
In 2024, Medicare Part D spent $11 million on Perphenazine across 194,000 claims for 23,000 beneficiaries.
How many Perphenazine products are on the market?
The Perphenazine drug market contains 40 NDCs from 11 manufacturers — 40 generic and 0 brand products.
What is the price range for Perphenazine?
NADAC reference prices for Perphenazine range from $0.1354 to $0.3911 per EA — the most expensive product costs about 2.9× the cheapest.
Which manufacturers make Perphenazine?
11 manufacturers list Perphenazine in NADAC. Ranked by number of NDCs, the largest are Endo USA Inc. (6), Zydus Pharmaceuticals (USA) Inc. (4), Actavis Pharma, Inc. (4), Sandoz Inc. (4), Heritage Pharmaceuticals Inc. (4).
How has the price of Perphenazine changed recently?
Over the past 7 days, 0 Perphenazine NDCs rose and 40 fell, with a market-wide average change of -8.3%.